Group 1 - The core point of the article is that Zhongyin Fashion (SZ 300901) announced the convening of its third board meeting on October 23, 2025, to review proposals including new daily related transactions [1] - For the year 2024, Zhongyin Fashion's revenue composition is entirely from the professional technical service industry, accounting for 100.0% [1] - As of the report date, Zhongyin Fashion has a market capitalization of 4.4 billion yuan [1] Group 2 - The article highlights that Chinese innovative drugs have generated $80 billion in overseas licensing deals this year, indicating a strong performance in the biopharmaceutical sector [1] - A conversation with Lu Gang, a partner at Chuangdong Investment, reveals that while the secondary market for biopharmaceuticals is thriving, fundraising in the primary market is facing challenges [1]
中胤时尚:10月23日召开董事会会议